Date Action Amount Person Type
Jan 14, 2019 Buy 129 709 Versant Venture Capital Iv, L.p. Common Stock
Jan 14, 2019 Buy 817 Versant Venture Capital Iv, L.p. Common Stock
Jan 07, 2019 Sell 3 859 Guyer David R Common Stock
Jan 04, 2019 Buy 6 250 Guyer David R Common Stock
Jan 04, 2019 Sell 6 250 Guyer David R Restricted Stock Units
Jan 03, 2019 Sell 3 637 Guyer David R Common Stock
Jan 03, 2019 Sell 3 637 Guyer David R Common Stock
Jan 02, 2019 Buy 5 750 Guyer David R Common Stock
Jan 02, 2019 Buy 5 750 Guyer David R Common Stock
Jan 02, 2019 Sell 5 750 Guyer David R Restricted Stock Units
Jan 02, 2019 Sell 5 750 Guyer David R Restricted Stock Units
Jan 01, 2019 Buy 32 000 Roberts Calvin W. Stock Option (Right to Buy)
Jan 01, 2019 Buy 0 Roberts Calvin W.
Dec 12, 2018 Buy 137 500 Guyer David R Stock Option (Right to Buy)
Dec 12, 2018 Buy 68 800 Guyer David R Restricted Stock Units
Dec 12, 2018 Buy 100 000 Carroll David Francis Stock Option (Right to Buy)
Dec 12, 2018 Buy 50 000 Carroll David Francis Restricted Stock Units
Dec 12, 2018 Buy 32 000 Graves Adrienne L Stock Option (Right to Buy)
Dec 12, 2018 Buy 0 Graves Adrienne L
Oct 30, 2018 Buy 0 Versant Venture Capital Iv, L.p. Common Stock
Oct 30, 2018 Buy 0 Versant Venture Capital Iv, L.p. Common Stock
Jul 02, 2018 Sell 2 736 Carroll David Francis Common Stock
Jul 01, 2018 Sell 7 500 Carroll David Francis Restricted Stock Units
Jul 01, 2018 Buy 7 500 Carroll David Francis Common Stock
May 23, 2018 Buy 16 000 Ross Michael Jay Stock Option (Right to Buy)
May 23, 2018 Buy 16 000 Ross Michael Jay Stock Option (Right to Buy)
May 23, 2018 Buy 16 000 Bolte Axel Stock Option (Right to Buy)
May 23, 2018 Buy 16 000 Henderson Jane Stock Option (Right to Buy)
May 23, 2018 Buy 16 000 Redlick David E Stock Option (Right to Buy)
Jan 05, 2018 Sell 602 Wood Barbara A Common Stock
Jan 05, 2018 Sell 3 798 Guyer David R Common Stock
Jan 04, 2018 Buy 1 200 Wood Barbara A Common Stock
Jan 04, 2018 Sell 1 200 Wood Barbara A Restricted Stock Units
Jan 04, 2018 Buy 6 250 Guyer David R Common Stock
Jan 04, 2018 Sell 6 250 Guyer David R Restricted Stock Units
Jan 03, 2018 Sell 3 516 Guyer David R Common Stock
Jan 03, 2018 Sell 694 Wood Barbara A Common Stock
Jan 03, 2018 Sell 356 Westby Keith Common Stock
Jan 02, 2018 Buy 5 750 Guyer David R Common Stock
Jan 02, 2018 Sell 5 750 Guyer David R Restricted Stock Units
Jan 02, 2018 Buy 1 375 Wood Barbara A Common Stock
Jan 02, 2018 Sell 1 375 Wood Barbara A Restricted Stock Units
Jan 02, 2018 Buy 781 Westby Keith Common Stock
Jan 02, 2018 Sell 781 Westby Keith Restricted Stock Units
Jan 02, 2018 Sell 5 289 Wood Barbara A Common Stock
Jan 02, 2018 Sell 16 520 Guyer David R Common Stock
Dec 29, 2017 Buy 12 140 Wood Barbara A Common Stock
Dec 29, 2017 Sell 12 140 Wood Barbara A Restricted Stock Units
Dec 29, 2017 Buy 30 480 Guyer David R Common Stock
Dec 29, 2017 Sell 30 480 Guyer David R Restricted Stock Units
Dec 19, 2017 Buy 150 000 Carroll David Francis Stock Option (Right to Buy)
Dec 19, 2017 Buy 150 000 Carroll David Francis Stock Option (Right to Buy)
Dec 19, 2017 Buy 300 000 Guyer David R Stock Option (Right to Buy)
Jul 05, 2017 Sell 3 284 Carroll David Francis Common Stock
Jul 05, 2017 Sell 17 678 Guyer David R Common Stock
Jul 05, 2017 Sell 5 119 Wood Barbara A Common Stock
Jul 01, 2017 Sell 7 500 Carroll David Francis Restricted Stock Units
Jul 01, 2017 Buy 7 500 Carroll David Francis Common Stock
Jun 30, 2017 Buy 30 480 Guyer David R Common Stock
Jun 30, 2017 Sell 30 480 Guyer David R Restricted Stock Units
Jun 30, 2017 Buy 12 140 Wood Barbara A Common Stock
Jun 30, 2017 Sell 12 140 Wood Barbara A Restricted Stock Units
Jun 13, 2017 Sell 700 Redlick David E Common Stock
May 19, 2017 Buy 16 000 Bolte Axel Stock Option (Right to Buy)
May 19, 2017 Buy 16 000 Redlick David E Stock Option (Right to Buy)
May 19, 2017 Buy 16 000 Ross Michael Jay Stock Option (right to buy)
May 18, 2017 Buy 1 750 Redlick David E Common Stock
May 18, 2017 Sell 1 750 Redlick David E Restricted Stock Units
May 18, 2017 Buy 1 750 Ross Michael Jay Common Stock
May 18, 2017 Sell 1 750 Ross Michael Jay Restricted Stock Units
Apr 24, 2017 Buy 63 500 Carroll David Francis Stock Option (Right To Buy)
Apr 24, 2017 Buy 30 000 Carroll David Francis Restricted Stock Units
Apr 24, 2017 Buy 55 000 Carroll David Francis Stock Option (right to buy)
Apr 24, 2017 Buy 38 000 Carroll David Francis Stock Option (right to buy)
Jan 30, 2017 Buy 260 000 Guyer David R Stock Option (Right to Buy)
Jan 30, 2017 Buy 38 000 Wood Barbara A Stock Option (Right to Buy)
Jan 17, 2017 Buy 24 280 Wood Barbara A Restricted Stock Units
Jan 17, 2017 Buy 60 960 Guyer David R Restricted Stock Units
Jan 05, 2017 Sell 589 Wood Barbara A Common Stock
Jan 05, 2017 Sell 3 785 Guyer David R Common Stock
Jan 04, 2017 Sell 1 200 Wood Barbara A Restricted Stock Units
Jan 04, 2017 Buy 1 200 Wood Barbara A Common Stock
Jan 04, 2017 Sell 6 250 Guyer David R Restricted Stock Units
Jan 04, 2017 Buy 6 250 Guyer David R Common Stock
Jan 03, 2017 Sell 3 484 Guyer David R Common Stock
Jan 03, 2017 Sell 675 Wood Barbara A Common Stock
Jan 02, 2017 Sell 5 750 Guyer David R Restricted Stock Units
Jan 02, 2017 Buy 5 750 Guyer David R Common Stock
Jan 02, 2017 Sell 1 375 Wood Barbara A Restricted Stock Units
Jan 02, 2017 Buy 1 375 Wood Barbara A Common Stock
Dec 30, 2016 Sell 6 000 Bolte Axel Common Stock
Dec 30, 2016 Sell 6 000 Bolte Axel Common Stock
Dec 23, 2016 Sell 746 Wood Barbara A Common Stock
Dec 15, 2016 Sell 1 405 487 Novo A/s Common Stock
Dec 14, 2016 Sell 2 205 000 Novo A/s Common Stock
Nov 01, 2016 Sell 22 060 Guyer David R Stock Options (Right to Buy)
Nov 01, 2016 Buy 22 060 Guyer David R Common Stock
Nov 01, 2016 Sell 10 530 Guyer David R Common Stock
Nov 01, 2016 Sell 7 710 Guyer David R Common Stock
Nov 01, 2016 Sell 3 820 Guyer David R Common Stock
INSIDER POWER
0
Last 100 transactions
Buy: 2 022 047 | Sell: 3 898 732 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 2 022 047 and sold 3 898 732 OPHT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Ophthotech Corporation

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also developing Zimura, an inhibitor of complement fac... OPHT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT